Women’s Health Strategy

Darren Henry Excerpts

Monday 8th March 2021 Commons Chamber

[Ms Dorries]

Ever since sodium valproate was first licensed, the Medicines and Healthcare Products Regulatory Agency’s position has been clear: valproate should only be used in women of childbearing potential if no other medicine is effective or tolerated. The MHRA has kept sodium valproate under constant review. The national director for patient safety has recently set up a clinically led valproate safety implementation group to consider the range of issues relating to valproate and prescribing and to explore options to review and reduce prescribing. In terms of the redress agency, we have looked at that across the board as a result of the Cumberlege recommendations. A number of redress processes are available already, and we did not want to complicate the landscape any further. We feel that, with the MHRA and the national director for patient safety, we have a response to sodium valproate.

[Darren Henry (Broxtowe) (Con) [V]]

I absolutely applaud the statement from the Minister, especially as it comes on International Women’s Day. I speak on behalf of Broxtowe constituent Sarah Kolawole and her daughter Ariella Kolawole, who sadly passed away shortly after being born in February 2019. I welcome all the research that has been conducted to explore why negative birth outcomes and traumatic births for pregnant women of black, African and Caribbean descent are more frequent than other ethnicities. As we move forward with our NHS long-term plan, does my hon. Friend agree that we must use this call for evidence to ensure that equal outcomes are achieved for mothers of all ethnicities?

[Ms Dorries]

I thank my hon. Friend for raising such an important point. It is the very reason I established the maternal inequalities oversight forum, so that I could learn from experts and organisations such as MBRRACE —Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries—and Maternity Voices about the issues that affect black, Asian and minority ethnic women in particular and why the statistics are as they are. I thank him for raising the individual case of his constituent, and I ask him to ask her to provide us with her evidence of what her experience was. It is really important that BAME women understand that we want to hear their stories and birth experiences. BAME women are five times more likely to die in childbirth than white women. We need to know what those issues are, and it is important to get that message out to those women.[Official Report, 12 March 2021, Vol. 690, c. 6MC.]